Skip to content

A study to validate an antiemesis questionnaire tool in blood cancer patients receiving chemotherapy

A study to validate the Multinational Association of Supportive Care in Cancer (MASCC) antiemesis tool for adolescent and adult patients with hematological malignancies receiving chemotherapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028252
Enrollment
90
Registered
2020-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C940- Acute erythroid leukemia Health Condition 2: C950- Acute leukemia of unspecified celltype Health Condition 3: C910- Acute lymphoblastic leukemia [ALL] Health Condition 4: C942- Acute megakaryoblastic leukemia Health Condition 5: C930- Acute monoblastic/monocytic leukemia Health Condition 6: C920- Acute myeloblastic leukemia Health Condition 7: C926- Acute myeloid leukemia with 11q23-abnormality Health Condition 8: C92A- Acute myeloid leukemia with multilineage dysplasia

Interventions

Intervention1: Not Applicable: Not Applicable Control Intervention1: Not Applicable: Not Applicable

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with confirmed diagnosis of Hematological malignancy 2. Aged >=15 years of age 3. Those who are intended to or are receiving chemotherapy at the time of inclusion into the study 4. ECOG Performance status 0-2 5. Should be able to read, understand and speak in Hindi or Marathi or Bengali

Exclusion criteria

Exclusion criteria: 1. Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
1.Content validity and Internal consistencyTimepoint: 1. One month

Secondary

MeasureTime frame
1.Construct validity 2.Criterion and Concurrent validityTimepoint: 1.At study completion(6 months) 2.At study completion(6 Months)

Countries

India

Contacts

Public ContactDr Hasmukh Jain

Tata Memorial Centre

dr.hkjain@gmail.com91-22-24177018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026